World Bank President David Malpas has said that India is fortunate to have a large producer of global vaccines such as the Serum Institute. He made this comment during a discussion with the media ahead of the upcoming meeting of the International Monetary Fund and the World Bank.
Malpas said I have had a lot of contact with the serum institute. It is not clear what are the needs of local production in the US, Europe, South Africa, or India to supply the local demands. Meanwhile, the CEO of Serum Institute, Adar Poonawala, is expected to start exporting the covid vaccine again from June.
At the same time, Adar Poonawala, CEO of Serum Institute, the world's largest vaccine maker Indian company, on Tuesday hoped to start exporting Kovid vaccine again from June. However, he said that it would be in the same situation if the impact of the new Coronavirus infection in India is less visible.
Poonawala said, but the continued increase in cases of corona infection in the country could further delay vaccine exports, as the Serum Institute of India would have to meet domestic needs first. Let us know that the Serum Institute is the most important supplier to the US-supported Kovacs program with the goal of making the vaccine equally available to everyone in the world.
But Kovacs announced a major setback to its vaccine program on 25 March, as the Serum Institute was forced to meet domestic demand due to the growing infection in India. Due to this, the global supply of 9 million vaccines was set to be delayed.